of the Max - MDC
of the Max - MDC
of the Max - MDC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Figure 2. Uncoupled astrocyte from <strong>the</strong> corpus<br />
callosum (left) and a coupled astrocyte network<br />
in <strong>the</strong> cortex (right)<br />
However, <strong>the</strong> effects <strong>of</strong> ATP on migration in cd39 deficient<br />
microglia can be restored by co-stimulation with adenosine<br />
or by addition <strong>of</strong> a soluble ectonucleotidase. We also tested<br />
<strong>the</strong> impact <strong>of</strong> cd39 deletion in a model <strong>of</strong> ischemia, in an<br />
entorhinal cortex lesion and in <strong>the</strong> facial nucleus after facial<br />
nerve lesion. The accumulation <strong>of</strong> microglia at <strong>the</strong> pathological<br />
sites was markedly decreased in cd39 deficient animals.<br />
We conclude that <strong>the</strong> co-stimulation <strong>of</strong> purinergic and<br />
adenosine receptors is a requirement for microglial migration<br />
and that <strong>the</strong> expression <strong>of</strong> cd39 controls <strong>the</strong><br />
ATP/adenosine balance (funded by DFG).<br />
Do microglial cells influence glioma cells?<br />
Gliomas comprise <strong>the</strong> majority <strong>of</strong> cerebral tumors and<br />
patients have a poor prognosis since <strong>the</strong>re is essentially no<br />
concept for successful treatment. Gliomas include astrocytomas,<br />
oligodendrogliomas, and <strong>the</strong> most malignant (and<br />
untreatable) brain tumor, <strong>the</strong> glioblastoma multiforme. We<br />
study <strong>the</strong> cellular properties <strong>of</strong> <strong>the</strong>se tumor cells and compare<br />
<strong>the</strong>m to normal glial cells with respect to <strong>the</strong>ir physiological<br />
properties and <strong>the</strong>ir abilities to proliferate and<br />
migrate. Currently, we are addressing <strong>the</strong> question as to<br />
whe<strong>the</strong>r microglial cells influence tumor cell behavior. In a<br />
slice culture, we injected a defined amount <strong>of</strong> tumor cells<br />
and quantified <strong>the</strong>ir migration within tissue. We found that<br />
microglial cell depletion from <strong>the</strong> slice slowed tumor invasion.<br />
Thus, <strong>the</strong> presence <strong>of</strong> microglial cells promotes <strong>the</strong><br />
invasion <strong>of</strong> tumor cells. Our results indicate that glioma<br />
cells change <strong>the</strong> expression pattern <strong>of</strong> microglial cells and<br />
we can mimic this influence even in vitro using glioma-conditioned<br />
medium. We could establish that glioma-conditioned<br />
medium triggers <strong>the</strong> upregulation <strong>of</strong> both metalloprotease-2<br />
and MT1-MMP, a membrane bound enzyme which<br />
converts <strong>the</strong> inactive precursor <strong>of</strong> metalloprotease-2 into its<br />
active form. Since metalloproteases degrade extracellular<br />
matrix, <strong>the</strong>ir presence favours <strong>the</strong> invasion <strong>of</strong> glioma cells.<br />
Thus glioma cells instruct microglial cells to help <strong>the</strong>m<br />
invade into healthy brain tissue. This research is funded by<br />
a binational BMBF grant with Bozena Kaminska, Warsaw<br />
(DLR 01GZ0304).<br />
162 Function and Dysfunction <strong>of</strong> <strong>the</strong> Nervous System